oncolytics biotech inc
(ONCY:Consolidated Issue listed on NASDAQ Capital Market)
Gerard T. Kennealey M.D., MA
Chief Medical Officer and Senior Vice President of Clinical Development, Oncolytics Biotech Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 4 different industries.|
Dr. Gerard T. Kennealey, M.D., MA serves as Vice President of Scientific Affairs of Cephalon Inc. Dr. Kennealey serves as the Chief Medical Officer and Senior Vice President of Clinical Development at Oncolytics Biotech Inc. Dr. Kennealey served as a Vice President of Business Development of Cephalon Inc. He served as Senior Vice President of Clinical Development at MGI Pharma, Inc. since May 2006. Dr. Kennealey is a board certified in both Medicine and Medical oncologist ...
1167 Kensington Crescent NWPhone: 403-670-7377
Calgary, Alberta T2N 1X7
Board Members Memberships*There is no Board Members Memberships data available.
Yale University School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|